• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ASBP

    Aspire Biopharma Holdings Inc.

    Subscribe to $ASBP
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2022

    Exchange: NASDAQ

    Recent Analyst Ratings for Aspire Biopharma Holdings Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Aspire Biopharma Holdings Inc. SEC Filings

    See more
    • Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      6/18/25 5:29:15 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      6/10/25 8:30:38 AM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.

      EFFECT - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      5/30/25 12:15:15 AM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aspire Biopharma Holdings Inc.

      SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

      5/19/25 8:30:03 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Aspire Biopharma Holdings Inc.

      10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      5/14/25 4:45:22 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form S-1 filed by Aspire Biopharma Holdings Inc.

      S-1 - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      5/13/25 5:21:07 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aspire Biopharma Holdings Inc.

      SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

      5/7/25 5:15:13 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      4/30/25 4:57:42 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aspire Biopharma Holdings Inc.

      SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

      4/23/25 7:48:38 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.

      EFFECT - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      4/22/25 12:15:15 AM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Aspire Biopharma Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

      4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/10/25 5:25:23 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

      4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/6/25 5:00:59 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Aspire Biopharma Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

      MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t

      4/16/25 7:00:00 AM ET
      $ASBP
      $BENF
      $BNZI
      $CIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance: Consumer Services
      Finance
    • Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

      MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register

      4/15/25 7:00:00 AM ET
      $ASBP
      $BENF
      $BNZI
      $CIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance: Consumer Services
      Finance

    Aspire Biopharma Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

      4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/10/25 5:25:23 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

      4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/6/25 5:00:59 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care